Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
1.380
-0.080 (-5.48%)
At close: Apr 28, 2026, 4:00 PM EDT
1.460
+0.080 (5.80%)
Pre-market: Apr 29, 2026, 6:51 AM EDT

Invivyd Revenue

In the year 2025, Invivyd had annual revenue of $53.43M with 110.47% growth. Invivyd had revenue of $17.21M in the quarter ending December 31, 2025, with 24.51% growth.

Revenue (ttm)
$53.43M
Revenue Growth
+110.47%
P/S Ratio
7.30
Revenue / Employee
$437,918
Employees
122
Market Cap
390.27M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202553.43M28.04M110.47%
Dec 31, 202425.38M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Vanda Pharmaceuticals 216.11M
Ginkgo Bioworks Holdings 170.16M
Niagen Bioscience 129.42M
Century Therapeutics 109.16M
Neurogene 925.00K
vTv Therapeutics 17.00K
Revenue Rankings